De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features (Q41925497)

14 October 2017

title

De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features (English)

1 reference

14 October 2017

Volkan Okur

1

0 references

Hans Bjornsson

object named as

Hans T Bjornsson

14

0 references

Mark A Tarnopolsky

12

object named as

Mark Tarnopolsky

1 reference

14 October 2017

19

Jane Juusola

1 reference

14 October 2017

Megan T Cho

2

1 reference

14 October 2017

Lindsay Henderson

3

1 reference

14 October 2017

Kyle Retterer

4

1 reference

14 October 2017

Michael Schneider

5

1 reference

14 October 2017

Shannon Sattler

6

1 reference

14 October 2017

Dmitriy Niyazov

7

1 reference

14 October 2017

Meron Azage

8

1 reference

14 October 2017

Sharon Smith

9

1 reference

14 October 2017

Jonathan Picker

10

1 reference

14 October 2017

Sharyn Lincoln

11

1 reference

14 October 2017

Lauren Brady

13

1 reference

14 October 2017

Carolyn Applegate

15

1 reference

14 October 2017

Amy Dameron

16

1 reference

14 October 2017

Rebecca Willaert

17

1 reference

14 October 2017

Berivan Baskin

18

1 reference

14 October 2017

Wendy K Chung

20

1 reference

14 October 2017

publication date

5 April 2016

1 reference

14 October 2017

1 reference

14 October 2017

volume

135

1 reference

14 October 2017

issue

7

1 reference

14 October 2017

page(s)

699-705

1 reference

An integrated map of genetic variation from 1,092 human genomes

14 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

Predominance of CK2α over CK2α' in the mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

CK2α is essential for embryonic morphogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

Structural determinants of protein kinase CK2 regulation by autoinhibitory polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

Active form of the protein kinase CK2 α2β2 holoenzyme is a strong complex with symmetric architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

Gene targeting of CK2 catalytic subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

Protein kinase CK2 in health and disease: From birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

Mutations in SPATA5 Are Associated with Microcephaly, Intellectual Disability, Seizures, and Hearing Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

Genomic organization and promoter identification of the human protein kinase CK2 catalytic subunit alpha (CSNK2A1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

Protein Kinase CK2 Mutants Defective in Substrate Recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

Basic Residues in the 74-83 and 191-198 Segments of Protein Kinase CK2 Catalytic Subunit are Implicated in Negative but not in Positive Regulation by the beta-Subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1661-Y

10.1007/S00439-016-1661-Y

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

14 October 2017

1033601373

0 references

1 reference